Rusch VW - Search Results

1

Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer.

Schoenfeld AJ, Rizvi HA, Memon D, Shaverdian N, Bott MJ, Sauter JL, Tsai CJ, Lihm J, Hoyos D, Plodkowski AJ, Perez-Johnston R, Sawan P, Egger JV, Greenbaum BD, Rimner A, Riely GJ, Rudin CM, Rusch VW, Gomez DR, Hellmann MD. Schoenfeld AJ, et al. Among authors: rusch vw. Clin Cancer Res. 2022 Sep 1;28(17):3797-3803. doi: 10.1158/1078-0432.CCR-22-0657. Clin Cancer Res. 2022. PMID: 35767426 Free PMC article.

2

Survival after resection of stage II non-small cell lung cancer.

Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Martini N, et al. Among authors: rusch vw. Ann Thorac Surg. 1992 Sep;54(3):460-5; discussion 466. doi: 10.1016/0003-4975(92)90435-7. Ann Thorac Surg. 1992. PMID: 1324654 Free article.

3

Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.

Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M, Dmitrovsky E. Rusch V, et al. Cancer Res. 1995 Nov 1;55(21):5038-42. Cancer Res. 1995. PMID: 7585548

4

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E. Rusch V, et al. Cancer Res. 1993 May 15;53(10 Suppl):2379-85. Cancer Res. 1993. PMID: 7683573

5

Incidence of local recurrence and second primary tumors in resected stage I lung cancer.

Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ. Martini N, et al. Among authors: rusch vw. J Thorac Cardiovasc Surg. 1995 Jan;109(1):120-9. doi: 10.1016/S0022-5223(95)70427-2. J Thorac Cardiovasc Surg. 1995. PMID: 7815787 Free article.

6

Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.

Rusch V, Klimstra D, Linkov I, Dmitrovsky E. Rusch V, et al. Cancer Res. 1995 Mar 15;55(6):1365-72. Cancer Res. 1995. PMID: 7882337

7

Management of non-small cell lung cancer with direct mediastinal involvement.

Martini N, Yellin A, Ginsberg RJ, Bains MS, Burt ME, McCormack PM, Rusch VW. Martini N, et al. Among authors: rusch vw. Ann Thorac Surg. 1994 Nov;58(5):1447-51. doi: 10.1016/0003-4975(94)91933-x. Ann Thorac Surg. 1994. PMID: 7979673

8

Resection of stage III non-small cell lung cancer following induction therapy.

Rusch VW. Rusch VW. World J Surg. 1995 Nov-Dec;19(6):817-22. doi: 10.1007/BF00299777. World J Surg. 1995. PMID: 8553672 Review.

9

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer.

Armstrong J, Raben A, Zelefsky M, Burt M, Leibel S, Burman C, Kutcher G, Harrison L, Hahn C, Ginsberg R, Rusch V, Kris M, Fuks Z. Armstrong J, et al. Radiother Oncol. 1997 Jul;44(1):17-22. doi: 10.1016/s0167-8140(97)01907-5. Radiother Oncol. 1997. PMID: 9288852

10

Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.

Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J, Dmitrovsky E. Rusch V, et al. Clin Cancer Res. 1997 Apr;3(4):515-22. Clin Cancer Res. 1997. PMID: 9815714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters